Geode Capital Management’s GT Biopharma GTBP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $85.4K | Buy |
23,837
+751
| +3% | +$2.69K | ﹤0.01% | 4104 |
|
|
2025
Q1 | $51.7K | Buy |
23,086
+8,187
| +55% | +$18.3K | ﹤0.01% | 4193 |
|
|
2024
Q4 | $45.5K | Sell |
14,899
-142
| -0.9% | -$433 | ﹤0.01% | 4257 |
|
|
2024
Q3 | $34.5K | Buy |
15,041
+3,857
| +34% | +$8.84K | ﹤0.01% | 4332 |
|
|
2024
Q2 | $31.7K | Hold |
11,184
| – | – | ﹤0.01% | 4377 |
|
|
2024
Q1 | $49.8K | Sell |
11,184
-326,131
| -97% | -$1.45M | ﹤0.01% | 4322 |
|
|
2023
Q4 | $86K | Hold |
337,315
| – | – | ﹤0.01% | 4227 |
|
|
2023
Q3 | $81.4K | Buy |
337,315
+113,871
| +51% | +$27.5K | ﹤0.01% | 4311 |
|
|
2023
Q2 | $69.7K | Hold |
223,444
| – | – | ﹤0.01% | 4439 |
|
|
2023
Q1 | $123K | Hold |
223,444
| – | – | ﹤0.01% | 4261 |
|
|
2022
Q4 | $199K | Sell |
223,444
-464
| -0.2% | -$413 | ﹤0.01% | 4107 |
|
|
2022
Q3 | $394K | Sell |
223,908
-43,396
| -16% | -$76.4K | ﹤0.01% | 3852 |
|
|
2022
Q2 | $799K | Sell |
267,304
-95,110
| -26% | -$284K | ﹤0.01% | 3523 |
|
|
2022
Q1 | $1.04M | Sell |
362,414
-25,534
| -7% | -$73.5K | ﹤0.01% | 3599 |
|
|
2021
Q4 | $1.18M | Sell |
387,948
-36,331
| -9% | -$111K | ﹤0.01% | 3633 |
|
|
2021
Q3 | $2.86M | Buy |
424,279
+77,673
| +22% | +$523K | ﹤0.01% | 3205 |
|
|
2021
Q2 | $5.37M | Buy |
346,606
+216,218
| +166% | +$3.35M | ﹤0.01% | 2853 |
|
|
2021
Q1 | $891K | Buy |
+130,388
| New | +$891K | ﹤0.01% | 3604 |
|